NP90726l Tildrakizumab (Ilumetri®)
A Voluntary Ex-Ante Transparency (VEAT) Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Framework (Supply)
- Duration
- not specified
- Value
- £844K
- Sector
- HEALTH
- Published
- 17 Mar 2026
- Delivery
- not specified
- Deadline
- n/a
Related Terms
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act
2 buyers
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Almirall Uxbridge
Description
Supply of Tildrakizumab (Ilumetri®) to NHS Scotland.
Total Quantity or Scope
The Authority has awarded this framework as a single supplier Framework per line to one (1) Framework Participant.
Award Detail
| 1 | Almirall (Uxbridge)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
Legal Justification
The medicine to be awarded to the framework agreement is protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.
Other Information
The estimated value of the Framework Agreement referred to in Section V.2.4 covers the eleven (11) month contract duration and the two (2) x twelve (12) month extension periods of the Framework Agreement. NOTE: To register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland Web Site at https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=823248. (SC Ref:823248)
Reference
- FTS 024266-2026